SCHEMBL809473

SCHEMBL809473

O=C1CCC/C1=C\c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.60
AKR1C1 Q04828 1/20 0.60
ALDH1A1 P00352 4/20 0.59
HTT P42858 2/20 0.59
USP18 Q9UMW8 2/20 0.56
UCHL5 Q9Y5K5 2/20 0.56
HSP90AA1 P07900 1/20 0.56
USP2 O75604 1/20 0.56
MAPT P10636 7/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CASP3 P42574 2/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
NPC1 O15118 2/20 0.51
HPGD P15428 1/20 0.51
METAP1 P53582 1/20 0.47
GAA P10253 3/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812720 1.00 AKR1C3 (0.60) AKR1C3AKR1C1ALDH1A1HTTUSP18
SCHEMBL29169528 0.97 USP18 (0.56) AKR1C3AKR1C1ALDH1A1HTTUSP18
SCHEMBL3437943 0.97 USP18 (0.56) AKR1C3AKR1C1ALDH1A1HTTUSP18
SCHEMBL3437940 0.97 USP18 (0.56) AKR1C3AKR1C1ALDH1A1HTTUSP18
SCHEMBL29506224 0.89 USP18 (0.52) AKR1C3AKR1C1ALDH1A1HTTUSP18
SCHEMBL9619486 0.88 USP18 (0.67) HTTUSP18UCHL5HSP90AA1USP2
SCHEMBL9619484 0.88 USP18 (0.67) HTTUSP18UCHL5HSP90AA1USP2
SCHEMBL27920741 0.81 ALDH1A1 (0.59) ALDH1A1HTTHSP90AA1MAPTRAB9A
SCHEMBL18610094 0.79 USP18 (0.50) ALDH1A1USP18UCHL5HSP90AA1USP2
SCHEMBL29506223 0.79 MAPT (0.56) ALDH1A1USP18UCHL5HSP90AA1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis SCO2, CBR1, CBR3 AKR1C3 4/4885AKR1C1 10/4885ALDH1A1 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.